Oku vela kuutima, kua kũlĩhĩwavo okuti, o infarto do miocárdio, ku lomboloka oku tatekiwa kuosonde oku enda vetimba liutima, kuenje ku koka olofa viosonde.
Eci ca siata oku pita omo lioku sitikiwa kuosonde yo vimo, okuti olonjanja vialua yi tunda koku livokiya kuosonde yovimo.
Ocikokoto caco ci kuete o colesterol, ulela, ovina vikuavo vi tunda vetimba liomunu, o cálcio kuenda o fibrina.
Eci ekokoto li tetoka, li pondola oku nena osonde okuti yi li kongela kuenje yi tateka osonde oku pitila vetimba liutima.
Ekambo liaco lio oxigenio li koka okuti olosinga viutima vi fa, kuenje eci ci tuala koku kuatiwa luvei wutima.
Oku nyõleha kuocimatamata caco ku limbukiwila konẽle yaco kuenda otembo yi pita tunde eci omunu a kuatiwa toke eci a sakuiwa.
Scott J: Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004, 14 (3): 271-9.
Liu Chung Ming C, Sesperez K, Ben-Sefer E, Arpon D, McGrath K, McClements L, Gentile C: Considerations to Model Heart Disease in Women with Preeclampsia and Cardiovascular Disease. Cells. 2021, 10 (4): .
Hansen J, Victor RG: Direct measurement of sympathetic activity: new insights into disordered blood pressure regulation in chronic renal failure. Curr Opin Nephrol Hypertens. 1994, 3 (6): 636-43.
LaMacchia JC, Roth MB: Aquaporins-2 and -4 regulate glycogen metabolism and survival during hyposmotic-anoxic stress in Caenorhabditis elegans. Am J Physiol Cell Physiol. 2015, 309 (2): C92-6.
Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR: Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015, 89 (9): 1401-38.
Lonn E: The clinical relevance of pharmacological blood pressure lowering mechanisms. Can J Cardiol. 2004, 20 Suppl B (): 83B-88B.
['Oku yuvula oku litenga vovitangi:']
['O Web site eyi, ya sandekiwila lika oku longisa omanu kuenda oku va ĩha olonumbi.']
['Nda o yongola oku sakuiwa, sandiliya ondotolo yi kuete uloño woku ci linga.']
['Kũlĩhĩsa okuti, uloño woku konomuisa atambululo apulilo, ka u pondola oku eca atambululo a suapo, ca piãla enene nda etendelo liaco ka lia suilepo.']
['Olonjanja viosi sandiliya ekuatiso liondotolo yove ale liondotolo yikuavo ya loñoloha kueci catiamẽla kocitangi cimue cuhayele. Lalimue eteke ku ka sepule ekuatiso liondotolo ale oku livala koku sandiliya omo liocina cimue wa tanga vo website yilo. Nda o sima okuti o kuete ocitangi cimue cuhayele, vilikiya lonjanga o 911 ale enda lonjanga kosipitali. Ka kuli ukamba umue pokati kondotolo lukuenje wa vela omo lio website yilo ale oku talavaya layo.']
['Oku liyelisa: omoko yoku soneha']
['O Digital Millennium Copyright Act yo 1998, 17 U.S.C. § 512 (o DMCA) yeca epondolo kolonalavayi vi kuete omoko yoku linga eci va sima okuti ovina vi sangiwa vo Internet vi nyõla omoko yavo yi sangiwa vocihandeleko co Estados Unidos. ']
['Nda ove o tava okuti ovina vimue via kapiwa vo Internet ale vovipama vikuavo vi kasi vonumbi yetu vi nyõla omoko yove yoku panga alivulu, ove (ale omunu wa ku nõla) o pondola oku tu tumisa esapulo limue oco tu piñale ovina viaco ale oku vi tateka.']
['Asapulo te a tumiwa loku soneha kuenda vo email (tala vokakasia "Kontato" oco o sange onumbi yo email).']
['DMCA yi kisika okuti esapulo liove lioku lavisa ovihandeleko viovihandeleko viupange mua kongela asapulo akuãimo: (1) elomboluilo liupange u kuete ovihandeleko viupange okuti owo wa lavisiwa; (2) elomboluilo liupange u kuete ovihandeleko viupange kuenda asapulo a tẽla oku ecelela oku sanga upange waco; (3) asapulo oku ku sandiliya, oku kongelamo onumbi yove, etendelo liotelefone kuenda onumbi yo email; (4) esapulo liove okuti ove o kuete ekolelo liwa okuti upange waco ka wa taviwile la muẽliaco ovihandeleko viupange, ale onumiwa yaye, ale oku kuama ovihandeleko; ']
['(5) ukanda umue wa sinaliwa love okuti u lekisa okuti esapulo liaco liocili kuenda o kuete omoko yoku teyuila omoko yove yoku soneha.']
['Kuenda (6) ondimbukiso yocikuata ale yo komputador yomunu ukuete omoko yoku linga upange waco ale yomunu umue o kuete omoko yoku linga upange waco vonduko yomunu ukuete omoko yaco. ']
['Nda kua kongelele ulandu wosi wa tukuiwa ndeti, ci tava okuti o livala poku tetulula ocitangi cove.']
['Oku Sapela']
['Tu tumise o email lapulilo ale ovisimĩlo viove.']
What is pathophysiology of heart attack?
The pathophysiology of a heart attack, also known as myocardial infarction, involves the disruption of blood flow to a part of the heart muscle, leading to the death of heart cells.
This typically occurs due to the obstruction of a coronary artery by a blood clot, which is often the result of atherosclerosis, a condition where plaque builds up in the arteries.
The plaque is made up of cholesterol, fatty substances, cellular waste products, calcium, and fibrin.
When a plaque ruptures, it can cause a blood clot to form, which can block the artery and prevent oxygen-rich blood from reaching the heart muscle.
This lack of oxygen causes the heart muscle cells to die, leading to a heart attack.
The extent of the damage depends on the size of the area supplied by the blocked artery and the time between the attack and treatment.
Symptoms of a heart attack can include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and pain in the arms, neck, jaw, or back.
Treatment for a heart attack usually involves restoring blood flow to the heart muscle as quickly as possible, either through medication or procedures such as angioplasty and stenting or coronary artery bypass surgery.
It is important to note that the pathophysiology of a heart attack is complex and involves multiple factors, including genetic, lifestyle, and environmental factors.
Risk factors for heart attack include high blood pressure, high cholesterol, smoking, diabetes, obesity, lack of physical activity, and a family history of heart disease.
Managing these risk factors can help reduce the likelihood of experiencing a heart attack.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Okuti']
['BioMedLib yi talavaya lolomakina violo computador (oku lilongisa omakina) oco yi linge apulilo kuenda atambululo.']
['Tu fetika leci ci soka 35 kolohuluwa vialivulu a lombolola ovina viatiamẽla kuhayele.']
